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Abstract 
 
 
 
 
 
 
 
The nontraumatic perforations of the small intestine are pathological entities with particular 
aspects in respect to diagnosis and treatment. These peculiarities derive from the nonspecific clinical 
expression of the peritonitis syndrome, and from the multitude of causes that might be the primary 
sources of the perforation: foreign bodies, inflammatory diseases, tumors, infectious diseases, etc. 
Accordingly, in most cases intestinal perforation is discovered only by laparotomy and the definitive 
diagnosis is available only after histopathologic examination. Small bowel malignancies are rare; 
among them, lymphomas rank third in frequency, being mostly B-cell non Hodgkin lymphomas. 
Only 10% of non-Hodgkin lymphomas are with T-cell. 
We report the case of a 57 years’ old woman with intestinal T-cell lymphoma, whose first 
clinical symptomatology was related to a complication represented by perforation of the small 
intestine. Laparotomy performed in emergency identified an ulcerative lesion with perforation in the 
jejunum, which required segmental enterectomy with anastomosis. The nonspecific clinical 
manifestations of intestinal lymphomas make from diagnosis a difficult procedure. Due to the fact 
that surgery does not have a definite place in the treatment of the small intestinal lymphomas (for 
cases complicated with perforation), and beyond the morbidity associated with the surgery performed 
in emergency conditions, prognosis of these patients is finally given by the possibility to control the 
systemic disease through adjuvant therapy.   
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Introduction 
The nontraumatic perforation of the small 
intestine is a rare pathological entity, which has 
particular aspects in respect to the clinical 
diagnosis and subsequent therapeutic conduct. 
These peculiarities derive especially from the 
difficulty of the preoperative diagnosis. In the 
majority of cases, the peritonitis syndrome imposes 
laparotomy which reveals the perforation of the 
intestine.  
In addition, there are multitude of causes that 
might be the primary sources of the perforation: 
foreign bodies, inflammatory diseases, tumors, 
infectious diseases, etc., so that only the 
histopathologic examination would be conclusive 
for the establishment of a definitive therapeutic 
approach. 
A variable geographical distribution can be 
observed when considering the etiology and 
incidence on age groups of the small intestine’s 
perforations. The infectious causes, such as 
typhoid fever or tuberculosis predominate in 
tropical areas and in the developing countries, 
being often found at young aged patients, 20-30 
years old, as opposed to the western countries 
where these cases appear much rarer and to older 
age groups, having as possible causes 
inflammatory diseases, tumors, radiotherapy, 
ingestion of foreign bodies or circulatory disorders 
(1- 4). 
The diagnosis becomes a challenging task 
especially in circumstances in which the patient 
has no significant medical history, so that the 
diagnosis can be established only after surgery. 
Malignant tumors of the small intestine are in 
general rare (about 3% among digestive 
neoplasms, and 0.5% within all cancers), having 
poor clinical expression and a relatively difficult 
diagnosis with usual investigative methods (5). 
Regarding their histology in last decades one 
can see a reversal of proportions in incidence of 
carcinoids as against adenocarcinomas while 
lymphomas ranks third in frequency after these 
with 17% of all malignant intestinal tumors (6). 
Non-Hodgkin's lymphomas are a heterogeneous 
group of neoplasms that can arise from B or T 
cells, progenitors or mature, or rarely from natural 
killer cells. 10 to 30 percent of patients with NHL 
have extra-nodal disease (7).The digestive tract 
represents the most frequent location of the non-
Hodgkin extra-nodal lymphoma, about 36%, 
affecting the stomach, small intestine and colon, in 
order of frequency (8). 
 
Case report 
We report the case of a 57 years’ old woman, 
with no significant medical history, admitted to the 
hospital for intense and diffuse abdominal pain, 
which emerged around 3 hour prior to the arrival at 
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the hospital. The patient described the debut of the 
pain in the upper abdomen, all of a sudden, like a 
„stubbing” feeling followed soon by the extending 
to the entire abdominal area.     
Physical examination reveals fever 380C, 
tachycardia and abdominal distention with 
tenderness to palpation and absence of bowel 
sounds. 
Laboratory tests showed normal values for 
leucocytes (WBC- 8250 /µL), neutrophil count not 
elevated (NEU- 6260/ µL), low values for 
lymphocyte count(LYM- 1170/µL/ 14,22%), red 
blood cells (RBC) 3,62 /*10^6 µL, Hemoglobin 
(Hb) 10.2g/dL and HTC31,9%. It was also found 
decreased levels for sodium (130,5mmol/L) and 
potassium 3,23mmol/L. No other changes were 
found in laboratory tests on admission.  
Plain X-ray film of the abdomen in upright 
position showed the presence of free air under the 
left diaphragm. Chest radiography did not identify 
changes in lungs or mediastinum.  Based on 
clinical, imaging and laboratory data the 
presumptive diagnosis was peritonitis from 
perforated viscera and laparotomy was decided. 
Midline vertical incision was made. The 
opening of the peritoneal cavity revealed small 
bowel content in peritoneum (succus entericus) 
and exploration showed a 3 millimeters perforation 
situated at the anti-mesenteric border on a jejunum 
loop about 60 cm from the Treitz angle (Figure 1).  
The perforation adjacent area had a pale 
appearance and the mesentery exhibited multiple 
enlarged lymph nodes which were conglomerated 
especially at the root of the mesentery forming 
large lymphadenopathy masses at this level. The 
other intraperitoneal organs including liver and 
spleen had no changes macroscopically. 
Small bowel resection and widely excision of 
adjacent mesentery was performed (Figure 2). The 
continuity was restored by end to end suturing 
anastomosis. Postoperative evolution was simple 
with no complications, and the patient was 
discharged 7 days after surgery. 
Histopathological examination revealed: 
Intestinal wall presenting a large ulceration 
about 1,5cm with perforation and diffuse 
transmural infiltration with large discoid cells 
 
Figure 1. 
 Banu P. et al. 
presenting oval and vesicular nuclei and 
eosinophilic cytoplasm in reduced amount; large 
number of areas of granulomatous inflammation. 
Multiple tumor cells with hyperchromic and 
hypertrophic nuclei; tumoral cells with multiple 
nuclei and atypical mitosis. Mesenteric 
lymphnodes exhibited an altered architecture with 
sinusal hystiocytosis and irregular germinal 
centers.  This appearance was suggestive of diffuse 
large cells intestinal lymphoma. 
Immunohistochemical examination revealed: 
CD3 diffuse positive in tumoral cells, CD2 
positive in tumoral cells, CD 25 positive in rare 
tumoral cells, CD5 negative in tumoral cells, CD30 
diffusely positive in tumoral cells cytoplasm and 
intense positive in some membranes; CD15 
positive in numerous granulocytes and in rare 
tumoral cells with granule appearance near the 
nuclei; CD20 and CD79a negative in tumoral cells; 
ALK negative in tumoral cells. 
Histopathological aspect and immuno-
histochemically tests are compatible with the 
diagnosis of Malign non Hodgkin lymphoma with 
T-cell type anaplastic large T-cell lymphoma ALK 
negative (ALCL, ALK ). Testing for hepatitis B, 
hepatitis C and HIV serology were negative using 
the western blotting procedure, and absence of the 
specific anti-HTLV I/II antibodies was confirmed. 
Discussion 
The primitive lymphomas of digestive tract 
remain rare entities, even though in the last 
decades a slight increase of their incidence (with 
percentage between 3 and 5) is reported. It is 
possible that this growth is due to the improvement 
of the immunohistochemical diagnosis which 
facilitates their diagnosis (8, 9). 
The cellular tissue from which these 
malignancies arise is represented by the MALT 
(mucosa associated lymphoid tissue), designating a 
heterogeneous population of cells with  
immunologic role quartered at the level of 
digestive tract mucosa, playing an essential role as 
a protection barrier of body from a large variety of 
antigens.  
The intestine hosts the lymphoid tissue in 
follicles, in Peyer’s plaques, in lamina propria and 
 
Figure 2. 
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intraepithelial and the mesenteric lymph nodes 
make connection to the peripheral immune system. 
The variety of the enteral lymphoid tissue’s 
cells is very wide, but each phenotype can be 
individualized with cytogenetic and 
immunohistochemical techniques, so allowing the 
anatomo-clinical framing of the lymphomas, the 
indication of the treatment and the prognostic 
assessment. 
Almost 90% of the gastrointestinal 
lymphomas derive from B lymphocytes and very 
few from T lymphocytes (10). They can be 
classified into three main categories: 
immunoproliferative small intestinal disease 
(IPSID), enteropathy-associated T cell lymphoma 
(EATL) which arises mostly in gluten-sensitive 
enteropathy and a third category comprising 
diffuse large B cell lymphoma, mantle cell 
lymphoma, Burkitt lymphoma and follicular 
lymphoma (11).  
What causes for lymphomas is still unknown, 
but a set of conditions seem to favor their 
development: bacterial infections (e.g. 
Helicobacter pylori or Helicobacter heilmannii), 
viruses (HTLV-1 in human T-cell lymphoma virus, 
Epstein-Barr in Burkitt lymphoma), severe 
immune deficiencies (AIDS, Waldmann disease) 
or celiac disease (8, 12, 13). 
Considering frequency order criteria, these 
locate predominant at stomach level, which sums 
50-60% from primary digestive tract lymphomas; 
20-50% affect the small intestine, especially the 
ileum. Very seldom, the primitive lymphomas can 
be found at the colon and rectum level (14- 17). 
The symptoms are uncharacteristic for 
intestinal lymphomas, for example abdominal 
bloating and distension, colic abdominal pain, loss 
of appetite, nausea or may have the clinical 
expression of an acute complication like 
perforation, occlusion or bleeding. Other general 
signs also nonspecific are so called B symptoms 
(fever, weight loss and night sweats) which 
occurring in the context of a lymphoma get a 
prognosis value (18). 
Classical methods of imaging diagnosis - 
barium studies and CT – can reveal tumors as 
intra- or extraluminal masses, polyps or parietal 
infiltration areas without offering data regarding 
the type of the lesion. On the other hand, 
endoscopy and particularly the “push and pull 
technique” with double balloon enteroscopy allows 
both biopsy sampling as well as execution of 
therapeutic maneuvers (19, 20). 
The gastrointestinal localization can be 
secondary in non-Hodgkin lymphomas, appearing 
most frequently in the context of a widespread 
nodal disease and much rarely as a primary 
location. 
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In order to decide a diagnose to this last form 
it is necessary for the lesion to be limited to the 
intestine’s level, the spleen and the liver not to be 
affected,  no mediastinal and peripheral lymph-
adenopathy must be present, and the number of 
white blood cell count must be in normal limits 
(21, 22, 23). 
The digestive lymphomas evaluation 
presumes a general balance that compulsory 
includes the exploration of renal function, hepatic 
function, serum electrolytes, blood test, lactic 
dehydrogenase, uric acid, chest x-ray, glycaemia 
and bone marrow biopsy. The evaluation is 
completed with the CT exam of the thorax, 
abdomen and pelvis.  The anamnestic data and the 
complete physical exam can suggest particular 
etiologies that can be confirmed by specific 
investigations.  
There is still not a consensus regarding the 
staging system for primary gastrointestinal 
lymphomas. The classical systems such as type 
Ann Arbor or Lugano seem to lend less, by 
omitting the disseminated forms or overlapping 
some distinctive clinical forms. 
The Paris staging resorts to TNM type 
classification through which one can assess the 
degree of the tumor extends in the depth of the 
digestive wall, the contiguous lymph nodes 
involvement and the specific spread,  contributing 
in this way to offer the therapist an easier and more 
complex working instrument (24). 
WHO (World Health Organization) scheme 
is the general frame of classification of lymphoid 
neoplasms unanimously accepted, wherewith 
different categories of diseases are defined by 
multidisciplinary approach including clinical, 
genetic, phenotypic and histological features (25). 
The latter two classifications – TNM staging 
system and WHO scheme–meet the broadest 
consensus use for primary gastrointestinal 
lymphomas. 
The gastrointestinal lymphomas treatment is 
multimodal and correlative with the 
histopathological type and the stage of the disease. 
Taking into consideration the large variety in 
lymphomas types, the therapeutically arsenal is 
complex too, but adaptable concurrently with a 
better understanding of pathogenesis and the 
molecular biology’s progress (26). 
The Helicobacter pylori infection is 
considered to be a predisposing factor to the 
development of the gastrointestinal tract 
lymphomas, even though it does not associate with 
a histopathological distinct type of these. The 
bacteria eradication treatment is part of the gastric 
lymphomas therapeutic strategies (27, 28). 
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The chemotherapy is administrated in cycles 
having types of cyclophosphamide-doxorubicin-
vincristine combinations, or cyclophosphamide-
vincristine to which it can be added prednisone or 
rituximab (29). 
Radiotherapy finds its utility in forms 
localized at stomach, duodenum or rectum level, 
but enteral lymphomas may have less benefit from 
it taking into account that they are often multifocal 
(30, 31). 
Only low-grade B-cell lymphoma of the 
small intestine can benefit from surgical resection 
as unique therapeutic method. In all the other 
cases, the role of surgery remains disputable, even 
though some studies show better survival rates of 
patients that were both having surgeries and 
following chemotherapy treatment, as compared to 
the ones who only had chemotherapy. The small 
number of patients included in these studies does 
not allow the establishment of definitive 
conclusions and the imposition of guidelines (32, 
33). 
Complications of gastrointestinal lymphomas 
are represented by obstruction, hemorrhage and 
perforation. For the small bowel as a particular 
location of lymphomas, perforation occurs in 9% 
of cases and it is associated with aggressive forms 
of the disease and chemotherapy. More than half of 
perforations occur in the first 4-5 weeks of 
chemotherapy (34, 35). 
Intraoperative appearance can be often in the 
form of an ulceration which can be 
macroscopically indistinguishable from other 
forms, and in this situation the histopathology 
examination becomes decisive in the establishment 
of the lesion’s nature especially when the 
perforation appears in a case of a patient with no 
relevant case history.  
In order to define the prognosis of these 
patients, several factors were taken into account 
but a real clinical significance have proved to have 
histological B type, symptoms, therapeutic 
modality, original site, LDH level and 
complication occurrences. 
Worst prognosis is associated with high-
grade lymphoma and intestinal location (36). 
According to other studies, even though the 
perforation is a life-threatening complication, it 
seems to not influence the final prognostic of these 
subjects, which is ultimately given by the 
possibility to control the main disease (34).  
 
Conclusions  
Primitive gastrointestinal lymphomas 
represent a rare pathological entity and among 
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these, only 10% are T-cell type. The absence of 
specific signs and symptoms makes clinical 
diagnosis to be particularly difficult for these ones.  
 These malignancies benefit from a 
multimodal treatment in which surgery has not yet 
a definitive place. The role of surgery in the 
treatment of GI lymphomas remains a topic in 
debate and in literature has conflicting data 
regarding the therapeutic benefit of the surgical 
act. This is largely a consequence of the small 
number of cases included in reports so that clear 
guidelines cannot be traced yet. 
 The occurrence of a complication such as 
perforation compels emergency surgical treatment 
and lesion’s resolving. Although perforation is a 
life threatening complication and beyond the 
morbidity of the surgical acts itself, the prognosis 
of these patients eventually is given by the ability 
to control the underlying disease.  
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